204 results on '"Cathomen T"'
Search Results
102. Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients.
- Author
-
Aushev M, Koller U, Mussolino C, Cathomen T, and Reichelt J
- Abstract
Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by dominant-negative mutations in either KRT5 or KRT14 , resulting in impairment of keratin filament structure and epidermal fragility. Currently, nearly 200 mutations distributed across the entire length of these genes are known to cause EBS. Genome editing using programmable nucleases enables the development of ex vivo gene therapies for dominant-negative genetic diseases. A clinically feasible strategy involves the disruption of the mutant allele while leaving the wild-type allele unaffected. Our aim was to develop a traceless approach to efficiently disrupt KRT5 alleles using TALENs displaying unbiased monoallelic disruption events and devise a strategy that allows for subsequent screening and isolation of correctly modified keratinocyte clones without the need for selection markers. Here we report on TALENs that efficiently disrupt the KRT5 locus in immortalized patient-derived EBS keratinocytes. Inactivation of the mutant allele using a TALEN working at sub-optimal levels resulted in restoration of intermediate filament architecture. This approach can be used for the functional inactivation of any mutant keratin allele regardless of the position of the mutation within the gene and is furthermore applicable to the treatment of other inherited skin disorders.
- Published
- 2017
- Full Text
- View/download PDF
103. Refining strategies to translate genome editing to the clinic.
- Author
-
Cornu TI, Mussolino C, and Cathomen T
- Subjects
- CRISPR-Cas Systems, Clinical Trials as Topic, Deoxyribonucleases, Dependovirus, Gene Editing legislation & jurisprudence, Genetic Vectors, Humans, Leukemia therapy, Transcription Activator-Like Effector Nucleases, Gene Editing methods, HIV Infections therapy, Hemoglobinopathies therapy, Hemophilia A therapy, Immunologic Deficiency Syndromes therapy, Muscular Dystrophies therapy, Neoplasms therapy
- Abstract
Recent progress in developing programmable nucleases, such as zinc-finger nucleases, transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)-Cas nucleases, have paved the way for gene editing to enter clinical practice. This translation is a result of combining high nuclease activity with high specificity and successfully applying this technology in various preclinical disease models, including infectious disease, primary immunodeficiencies, hemoglobinopathies, hemophilia and muscular dystrophy. Several clinical gene-editing trials, both ex vivo and in vivo, have been initiated in the past 2 years, including studies that aim to knockout genes as well as to add therapeutic transgenes. Here we discuss the advances made in the gene-editing field in recent years, and specify priorities that need to be addressed to expand therapeutic genome editing to further disease entities.
- Published
- 2017
- Full Text
- View/download PDF
104. Therapeutic genome editing with engineered nucleases.
- Author
-
Haas SA, Dettmer V, and Cathomen T
- Subjects
- Humans, Transfection methods, Deoxyribonucleases genetics, Gene Editing methods, Genetic Therapy methods, Genome, Human genetics, Molecular Targeted Therapy methods, Protein Engineering methods
- Abstract
Targeted genome editing with designer nucleases, such as zinc finger nucleases, TALE nucleases, and CRISPR-Cas nucleases, has heralded a new era in gene therapy. Genetic disorders, which have not been amenable to conventional gene-addition-type gene therapy approaches, such as disorders with dominant inheritance or diseases caused by mutations in tightly regulated genes, can now be treated by precise genome surgery. Moreover, engineered nucleases enable novel genetic interventions to fight infectious diseases or to improve cancer immunotherapies. Here, we review the development of the different classes of programmable nucleases, discuss the challenges and improvements in translating gene editing into clinical use, and give an outlook on what applications can expect to enter the clinic in the near future.
- Published
- 2017
- Full Text
- View/download PDF
105. Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase.
- Author
-
Eggenschwiler R, Moslem M, Fráguas MS, Galla M, Papp O, Naujock M, Fonfara I, Gensch I, Wähner A, Beh-Pajooh A, Mussolino C, Tauscher M, Steinemann D, Wegner F, Petri S, Schambach A, Charpentier E, Cathomen T, and Cantz T
- Subjects
- Alleles, Humans, CRISPR-Cas Systems, Gene Silencing, Induced Pluripotent Stem Cells metabolism, Transcription, Genetic
- Abstract
Homology directed repair (HDR)-based genome editing via selectable long flanking arm donors can be hampered by local transgene silencing at transcriptionally silent loci. Here, we report efficient bi-allelic modification of a silent locus in patient-derived hiPSC by using Cas9 nickase and a silencing-resistant donor construct that contains an excisable selection/counter-selection cassette. To identify the most active single guide RNA (sgRNA)/nickase combinations, we employed a lentiviral vector-based reporter assay to determine the HDR efficiencies in cella. Next, we used the most efficient pair of sgRNAs for targeted integration of an improved, silencing-resistant plasmid donor harboring a piggyBac-flanked puroΔtk cassette. Moreover, we took advantage of a dual-fluorescence selection strategy for bi-allelic targeting and achieved 100% counter-selection efficiency after bi-allelic excision of the selection/counter-selection cassette. Together, we present an improved system for efficient bi-allelic modification of transcriptionally silent loci in human pluripotent stem cells.
- Published
- 2016
- Full Text
- View/download PDF
106. Failure to detect DNA-guided genome editing using Natronobacterium gregoryi Argonaute.
- Author
-
Lee SH, Turchiano G, Ata H, Nowsheen S, Romito M, Lou Z, Ryu SM, Ekker SC, Cathomen T, and Kim JS
- Subjects
- DNA, Gene Editing, Natronobacterium
- Published
- 2016
- Full Text
- View/download PDF
107. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
- Author
-
Bednarski C, Tomczak K, Vom Hövel B, Weber WM, and Cathomen T
- Subjects
- Base Sequence, Cell Line, Cystic Fibrosis genetics, DNA, Complementary genetics, Deoxyribonucleases chemistry, Deoxyribonucleases metabolism, Epithelial Cells metabolism, Genotype, Humans, Mutation, RNA, Messenger genetics, RNA, Messenger metabolism, Zinc Fingers, Cystic Fibrosis pathology, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Cystic Fibrosis Transmembrane Conductance Regulator metabolism, Exons genetics, Gene Editing methods, Genetic Loci genetics
- Abstract
In vitro disease models have enabled insights into the pathophysiology of human disease as well as the functional evaluation of new therapies, such as novel genome engineering strategies. In the context of cystic fibrosis (CF), various cellular disease models have been established in recent years, including organoids based on induced pluripotent stem cell technology that allowed for functional readouts of CFTR activity. Yet, many of these in vitro CF models require complex and expensive culturing protocols that are difficult to implement and may not be amenable for high throughput screens. Here, we show that a simple cellular CF disease model based on the bronchial epithelial ΔF508 cell line CFBE41o- can be used to validate functional CFTR correction. We used an engineered nuclease to target the integration of a super-exon, encompassing the sequences of CFTR exons 11 to 27, into exon 11 and re-activated endogenous CFTR expression by treating CFBE41o- cells with a demethylating agent. We demonstrate that the integration of this super-exon resulted in expression of a corrected mRNA from the endogenous CFTR promoter and used short-circuit current measurements in Ussing chambers to corroborate restored ion transport of the repaired CFTR channels. In conclusion, this study proves that the targeted integration of a large super-exon in CFTR exon 11 leads to functional correction of CFTR, suggesting that this strategy can be used to functionally correct all CFTR mutations located downstream of the 5' end of exon 11.
- Published
- 2016
- Full Text
- View/download PDF
108. Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome.
- Author
-
Müller M, Lee CM, Gasiunas G, Davis TH, Cradick TJ, Siksnys V, Bao G, Cathomen T, and Mussolino C
- Subjects
- Base Sequence, Binding Sites, Cell Line, Endonucleases metabolism, Enzyme Activation, Genetic Vectors, Humans, Protein Binding, RNA, Guide, CRISPR-Cas Systems, Substrate Specificity, CRISPR-Cas Systems, Gene Editing, Genome, Human, Streptococcus thermophilus enzymology, Streptococcus thermophilus genetics
- Abstract
RNA-guided nucleases (RGNs) based on the type II CRISPR-Cas9 system of Streptococcus pyogenes (Sp) have been widely used for genome editing in experimental models. However, the nontrivial level of off-target activity reported in several human cells may hamper clinical translation. RGN specificity depends on both the guide RNA (gRNA) and the protospacer adjacent motif (PAM) recognized by the Cas9 protein. We hypothesized that more stringent PAM requirements reduce the occurrence of off-target mutagenesis. To test this postulation, we generated RGNs based on two Streptococcus thermophilus (St) Cas9 proteins, which recognize longer PAMs, and performed a side-by-side comparison of the three RGN systems targeted to matching sites in two endogenous human loci, PRKDC and CARD11. Our results demonstrate that in samples with comparable on-target cleavage activities, significantly lower off-target mutagenesis was detected using St-based RGNs as compared to the standard Sp-RGNs. Moreover, similarly to SpCas9, the StCas9 proteins accepted truncated gRNAs, suggesting that the specificities of St-based RGNs can be further improved. In conclusion, our results show that Cas9 proteins with longer or more restrictive PAM requirements provide a safe alternative to SpCas9-based RGNs and hence a valuable option for future human gene therapy applications.
- Published
- 2016
- Full Text
- View/download PDF
109. Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition.
- Author
-
Ordovás L, Boon R, Pistoni M, Chen Y, Wolfs E, Guo W, Sambathkumar R, Bobis-Wozowicz S, Helsen N, Vanhove J, Berckmans P, Cai Q, Vanuytsel K, Eggermont K, Vanslembrouck V, Schmidt BZ, Raitano S, Van Den Bosch L, Nahmias Y, Cathomen T, Struys T, and Verfaillie CM
- Subjects
- Cells, Cultured, DNA Methylation, Dependovirus genetics, Embryonic Stem Cells cytology, Gene Silencing, Genetic Loci, Hepatocytes metabolism, Humans, Induced Pluripotent Stem Cells cytology, Recombinases genetics, Embryonic Stem Cells metabolism, Gene Targeting methods, Hepatocytes cytology, Induced Pluripotent Stem Cells metabolism, Recombinases metabolism, Transgenes
- Abstract
Tools for rapid and efficient transgenesis in "safe harbor" loci in an isogenic context remain important to exploit the possibilities of human pluripotent stem cells (hPSCs). We created hPSC master cell lines suitable for FLPe recombinase-mediated cassette exchange (RMCE) in the AAVS1 locus that allow generation of transgenic lines within 15 days with 100% efficiency and without random integrations. Using RMCE, we successfully incorporated several transgenes useful for lineage identification, cell toxicity studies, and gene overexpression to study the hepatocyte lineage. However, we observed unexpected and variable transgene expression inhibition in vitro, due to DNA methylation and other unknown mechanisms, both in undifferentiated hESC and differentiating hepatocytes. Therefore, the AAVS1 locus cannot be considered a universally safe harbor locus for reliable transgene expression in vitro, and using it for transgenesis in hPSC will require careful assessment of the function of individual transgenes., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
110. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
- Author
-
Dreyer AK, Hoffmann D, Lachmann N, Ackermann M, Steinemann D, Timm B, Siler U, Reichenbach J, Grez M, Moritz T, Schambach A, and Cathomen T
- Subjects
- Cell Differentiation, Cell Line, Deoxyribonucleases genetics, Genetic Engineering, Granulocytes cytology, Granulomatous Disease, Chronic therapy, Humans, Induced Pluripotent Stem Cells cytology, Myeloid Cells cytology, NADPH Oxidase 2, Genetic Therapy, Granulocytes metabolism, Granulomatous Disease, Chronic genetics, Induced Pluripotent Stem Cells metabolism, Membrane Glycoproteins genetics, NADPH Oxidases genetics
- Abstract
X-linked chronic granulomatous disease (X-CGD) is an inherited disorder of the immune system. It is characterized by a defect in the production of reactive oxygen species (ROS) in phagocytic cells due to mutations in the NOX2 locus, which encodes gp91phox. Because the success of retroviral gene therapy for X-CGD has been hampered by insertional activation of proto-oncogenes, targeting the insertion of a gp91phox transgene into potential safe harbor sites, such as AAVS1, may represent a valid alternative. To conceptually evaluate this strategy, we generated X-CGD patient-derived induced pluripotent stem cells (iPSCs), which recapitulate the cellular disease phenotype upon granulocytic differentiation. We examined AAVS1-specific zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) for their efficacy to target the insertion of a myelo-specific gp91phox cassette to AAVS1. Probably due to their lower cytotoxicity, TALENs were more efficient than ZFNs in generating correctly targeted iPSC colonies, but all corrected iPSC clones showed no signs of mutations at the top-ten predicted off-target sites of both nucleases. Upon differentiation of the corrected X-CGD iPSCs, gp91phox mRNA levels were highly up-regulated and the derived granulocytes exhibited restored ROS production that induced neutrophil extracellular trap (NET) formation. In conclusion, we demonstrate that TALEN-mediated integration of a myelo-specific gp91phox transgene into AAVS1 of patient-derived iPSCs represents a safe and efficient way to generate autologous, functionally corrected granulocytes., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
111. Proven and novel strategies for efficient editing of the human genome.
- Author
-
Mussolino C, Mlambo T, and Cathomen T
- Subjects
- Humans, Genetic Engineering, Genome, Human
- Abstract
Targeted gene editing with designer nucleases has become increasingly popular. The most commonly used designer nuclease platforms are engineered meganucleases, zinc-finger nucleases, transcription activator-like effector nucleases and the clustered regularly interspaced short palindromic repeat/Cas9 system. These powerful tools have greatly facilitated the generation of plant and animal models for basic research, and harbor an enormous potential for applications in biotechnology and gene therapy. This review recapitulates proven concepts of targeted genome engineering in primary human cells and elaborates on novel concepts that became possible with the dawn of RNA-guided nucleases and RNA-guided transcription factors., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
112. Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.
- Author
-
Rahman SH, Kuehle J, Reimann C, Mlambo T, Alzubi J, Maeder ML, Riedel H, Fisch P, Cantz T, Rudolph C, Mussolino C, Joung JK, Schambach A, and Cathomen T
- Subjects
- Animals, DNA-Activated Protein Kinase deficiency, DNA-Activated Protein Kinase genetics, DNA-Binding Proteins deficiency, DNA-Binding Proteins genetics, Disease Models, Animal, Fibroblasts cytology, Fibroblasts metabolism, Genome, Genotyping Techniques, HEK293 Cells, Humans, Induced Pluripotent Stem Cells cytology, Male, Mice, NIH 3T3 Cells, Nuclear Proteins deficiency, Nuclear Proteins genetics, Phenotype, Protein Kinases genetics, T-Lymphocytes metabolism, Zinc Fingers, Cell Differentiation, DNA-Activated Protein Kinase metabolism, DNA-Binding Proteins metabolism, Nuclear Proteins metabolism, Protein Kinases metabolism, Signal Transduction, T-Lymphocytes cytology
- Abstract
In vitro disease modeling based on induced pluripotent stem cells (iPSCs) provides a powerful system to study cellular pathophysiology, especially in combination with targeted genome editing and protocols to differentiate iPSCs into affected cell types. In this study, we established zinc-finger nuclease-mediated genome editing in primary fibroblasts and iPSCs generated from a mouse model for radiosensitive severe combined immunodeficiency (RS-SCID), a rare disorder characterized by cellular sensitivity to radiation and the absence of lymphocytes due to impaired DNA-dependent protein kinase (DNA-PK) activity. Our results demonstrate that gene editing in RS-SCID fibroblasts rescued DNA-PK dependent signaling to overcome radiosensitivity. Furthermore, in vitro T-cell differentiation from iPSCs was employed to model the stage-specific T-cell maturation block induced by the disease causing mutation. Genetic correction of the RS-SCID iPSCs restored T-lymphocyte maturation, polyclonal V(D)J recombination of the T-cell receptor followed by successful beta-selection. In conclusion, we provide proof that iPSC-based in vitro T-cell differentiation is a valuable paradigm for SCID disease modeling, which can be utilized to investigate disorders of T-cell development and to validate gene therapy strategies for T-cell deficiencies. Moreover, this study emphasizes the significance of designer nucleases as a tool for generating isogenic disease models and their future role in producing autologous, genetically corrected transplants for various clinical applications.
- Published
- 2015
- Full Text
- View/download PDF
113. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.
- Author
-
Schott JW, Jaeschke NM, Hoffmann D, Maetzig T, Ballmaier M, Godinho T, Cathomen T, and Schambach A
- Subjects
- Humans, Kinetics, Lentivirus genetics, Plasmids genetics, Transgenes genetics, Gene Expression, Genetic Vectors, Transduction, Genetic methods
- Abstract
Lentiviral and gammaretroviral vectors are state-of-the-art tools for transgene expression within target cells. The integration of these vectors can be deliberately suppressed to derive a transient gene expression system based on extrachromosomal circular episomes with intact coding regions. These episomes can be used to deliver DNA templates and to express RNA or protein. Importantly, transient gene transfer avoids the genotoxic side effects of integrating vectors. Restricting their applicability, episomes are rapidly lost upon dilution in dividing target cells. Addressing this limitation, we could establish comparably stable percentages of transgene-positive cells over prolonged time periods in proliferating cells by repeated transductions. Flow cytometry was applied for kinetic analyses to decipher the impact of individual parameters on the kinetics of fluoroprotein expression after episomal retransduction and to visualize sequential and simultaneous transfer of heterologous fluoroproteins. Expression windows could be exactly timed by the number of transduction steps. The kinetics of signal loss was affected by the cell proliferation rate. The transfer of genes encoding fluoroproteins with different half-lives revealed a major impact of protein stability on temporal signal distribution and accumulation, determining optimal retransduction intervals. In addition, sequential transductions proved broad applicability in different cell types and using different envelope pseudotypes without receptor overload. Stable percentages of cells coexpressing multiple transgenes could be generated upon repeated coadministration of different episomal vectors. Alternatively, defined patterns of transgene expression could be recapitulated by sequential transductions. Altogether, we established a methodology to control and adjust a temporally defined window of transgene expression using retroviral episomal vectors. Combined with the highly efficient cell entry of these vectors while avoiding integration, the developed technology is of great significance for a broad panel of applications, including transcription-factor-based induced cell fate conversion and controlled transfer of genetically encoded RNA- or protein-based drugs., (© 2015 International Society for Advancement of Cytometry.)
- Published
- 2015
- Full Text
- View/download PDF
114. Genome editing technologies: defining a path to clinic.
- Author
-
Corrigan-Curay J, O'Reilly M, Kohn DB, Cannon PM, Bao G, Bushman FD, Carroll D, Cathomen T, Joung JK, Roth D, Sadelain M, Scharenberg AM, von Kalle C, Zhang F, Jambou R, Rosenthal E, Hassani M, Singh A, and Porteus MH
- Subjects
- Animals, DNA Breaks, Double-Stranded, DNA Repair, Gene Rearrangement, Genetic Engineering methods, Humans, Models, Animal, Mutagenicity Tests, Translational Research, Biomedical, Genome, Genomics methods
- Published
- 2015
- Full Text
- View/download PDF
115. Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia.
- Author
-
Raitano S, Ordovàs L, De Muynck L, Guo W, Espuny-Camacho I, Geraerts M, Khurana S, Vanuytsel K, Tóth BI, Voets T, Vandenberghe R, Cathomen T, Van Den Bosch L, Vanderhaeghen P, Van Damme P, and Verfaillie CM
- Subjects
- Biomarkers, Cell Differentiation, Cell Line, Frontotemporal Dementia therapy, Gene Expression Profiling, Haploinsufficiency, Humans, Induced Pluripotent Stem Cells cytology, Intercellular Signaling Peptides and Proteins metabolism, Mutation, Neural Stem Cells cytology, Neural Stem Cells metabolism, Phenotype, Progranulins, Time Factors, Transcription, Genetic, Transcriptome, Wnt Signaling Pathway, Frontotemporal Dementia genetics, Frontotemporal Dementia metabolism, Gene Expression, Induced Pluripotent Stem Cells metabolism, Intercellular Signaling Peptides and Proteins genetics, Neurogenesis genetics, Neurons metabolism
- Abstract
To understand how haploinsufficiency of progranulin (PGRN) causes frontotemporal dementia (FTD), we created induced pluripotent stem cells (iPSCs) from patients carrying the GRN(IVS1+5G > C) mutation (FTD-iPSCs). FTD-iPSCs were fated to cortical neurons, the cells most affected in FTD. Although generation of neuroprogenitors was unaffected, their further differentiation into CTIP2-, FOXP2-, or TBR1-TUJ1 double-positive cortical neurons, but not motorneurons, was significantly decreased in FTD-neural progeny. Zinc finger nuclease-mediated introduction of GRN cDNA into the AAVS1 locus corrected defects in cortical neurogenesis, demonstrating that PGRN haploinsufficiency causes inefficient cortical neuron generation. RNA sequencing analysis confirmed reversal of the altered gene expression profile following genetic correction. We identified the Wnt signaling pathway as one of the top defective pathways in FTD-iPSC-derived neurons, which was reversed following genetic correction. Differentiation of FTD-iPSCs in the presence of a WNT inhibitor mitigated defective corticogenesis. Therefore, we demonstrate that PGRN haploinsufficiency hampers corticogenesis in vitro., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
116. Editing CCR5: a novel approach to HIV gene therapy.
- Author
-
Cornu TI, Mussolino C, Bloom K, and Cathomen T
- Subjects
- Animals, Endonucleases genetics, Endonucleases metabolism, HIV-1 physiology, Humans, Molecular Targeted Therapy methods, Receptors, CCR5 metabolism, Virus Internalization, Acquired Immunodeficiency Syndrome therapy, Genetic Therapy methods, RNA Editing, Receptors, CCR5 genetics
- Abstract
Acquired immunodeficiency syndrome (AIDS) is a life-threatening disorder caused by infection of individuals with the human immunodeficiency virus (HIV). Entry of HIV-1 into target cells depends on the presence of two surface proteins on the cell membrane: CD4, which serves as the main receptor, and either CCR5 or CXCR4 as a co-receptor. A limited number of people harbor a genomic 32-bp deletion in the CCR5 gene (CCR5∆32), leading to expression of a truncated gene product that provides resistance to HIV-1 infection in individuals homozygous for this mutation. Moreover, allogeneic hematopoietic stem cell (HSC) transplantation with CCR5∆32 donor cells seems to confer HIV-1 resistance to the recipient as well. However, since Δ32 donors are scarce and allogeneic HSC transplantation is not exempt from risks, the development of gene editing tools to knockout CCR5 in the genome of autologous cells is highly warranted. Targeted gene editing can be accomplished with designer nucleases, which essentially are engineered restriction enzymes that can be designed to cleave DNA at specific sites. During repair of these breaks, the cellular repair pathway often introduces small mutations at the break site, which makes it possible to disrupt the ability of the targeted locus to express a functional protein, in this case CCR5. Here, we review the current promise and limitations of CCR5 gene editing with engineered nucleases, including factors affecting the efficiency of gene disruption and potential off-target effects.
- Published
- 2015
- Full Text
- View/download PDF
117. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
- Author
-
Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, Bulashevska A, Petersen BS, Schäffer AA, Grüning BA, Unger S, Frede N, Baumann U, Witte T, Schmidt RE, Dueckers G, Niehues T, Seneviratne S, Kanariou M, Speckmann C, Ehl S, Rensing-Ehl A, Warnatz K, Rakhmanov M, Thimme R, Hasselblatt P, Emmerich F, Cathomen T, Backofen R, Fisch P, Seidl M, May A, Schmitt-Graeff A, Ikemizu S, Salzer U, Franke A, Sakaguchi S, Walker LSK, Sansom DM, and Grimbacher B
- Subjects
- Adolescent, Adult, Agammaglobulinemia immunology, Anemia, Hemolytic, Autoimmune genetics, Anemia, Hemolytic, Autoimmune immunology, Animals, Autoimmune Diseases immunology, B-Lymphocytes immunology, B7-1 Antigen metabolism, CTLA-4 Antigen immunology, Child, Codon, Nonsense, Endocytosis genetics, Endocytosis immunology, Exons, Female, Granuloma genetics, Granuloma immunology, Heterozygote, Humans, Immune System Diseases genetics, Lung Diseases, Interstitial genetics, Lung Diseases, Interstitial immunology, Male, Mice, Middle Aged, Mutation, Missense, Pedigree, Polyendocrinopathies, Autoimmune genetics, Polyendocrinopathies, Autoimmune immunology, Purpura, Thrombocytopenic, Idiopathic genetics, Purpura, Thrombocytopenic, Idiopathic immunology, Recurrence, Respiratory Tract Infections genetics, Respiratory Tract Infections immunology, Syndrome, Young Adult, Agammaglobulinemia genetics, Autoimmune Diseases genetics, CTLA-4 Antigen genetics, T-Lymphocytes, Regulatory immunology
- Abstract
The protein cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of immune responses, and its loss causes fatal autoimmunity in mice. We studied a large family in which five individuals presented with a complex, autosomal dominant immune dysregulation syndrome characterized by hypogammaglobulinemia, recurrent infections and multiple autoimmune clinical features. We identified a heterozygous nonsense mutation in exon 1 of CTLA4. Screening of 71 unrelated patients with comparable clinical phenotypes identified five additional families (nine individuals) with previously undescribed splice site and missense mutations in CTLA4. Clinical penetrance was incomplete (eight adults of a total of 19 genetically proven CTLA4 mutation carriers were considered unaffected). However, CTLA-4 protein expression was decreased in regulatory T cells (Treg cells) in both patients and carriers with CTLA4 mutations. Whereas Treg cells were generally present at elevated numbers in these individuals, their suppressive function, CTLA-4 ligand binding and transendocytosis of CD80 were impaired. Mutations in CTLA4 were also associated with decreased circulating B cell numbers. Taken together, mutations in CTLA4 resulting in CTLA-4 haploinsufficiency or impaired ligand binding result in disrupted T and B cell homeostasis and a complex immune dysregulation syndrome.
- Published
- 2014
- Full Text
- View/download PDF
118. Adenoviral vector DNA for accurate genome editing with engineered nucleases.
- Author
-
Holkers M, Maggio I, Henriques SF, Janssen JM, Cathomen T, and Gonçalves MA
- Subjects
- Cell Line, Cell Separation, Gene Targeting methods, Genome, HEK293 Cells, HeLa Cells, Humans, Polymerase Chain Reaction, Recombination, Genetic, Repetitive Sequences, Nucleic Acid, Reproducibility of Results, Adenoviridae genetics, DNA chemistry, DNA, Viral genetics, Deoxyribonucleases chemistry, Genetic Engineering methods
- Abstract
Engineered sequence-specific nucleases and donor DNA templates can be customized to edit mammalian genomes via the homologous recombination (HR) pathway. Here we report that the nature of the donor DNA greatly affects the specificity and accuracy of the editing process following site-specific genomic cleavage by transcription activator-like effector nucleases (TALENs) and clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 nucleases. By applying these designer nucleases together with donor DNA delivered as protein-capped adenoviral vector (AdV), free-ended integrase-defective lentiviral vector or nonviral vector templates, we found that the vast majority of AdV-modified human cells underwent scarless homology-directed genome editing. In contrast, a significant proportion of cells exposed to free-ended or to covalently closed HR substrates were subjected to random and illegitimate recombination events. These findings are particularly relevant for genome engineering approaches aiming at high-fidelity genetic modification of human cells.
- Published
- 2014
- Full Text
- View/download PDF
119. Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.
- Author
-
Mock U, Riecken K, Berdien B, Qasim W, Chan E, Cathomen T, and Fehse B
- Subjects
- Drug Delivery Systems, Endonucleases genetics, Gene Expression Regulation, Gene Transfer Techniques, Genome, Human, HEK293 Cells, Humans, RNA, Messenger genetics, Receptors, CCR5 genetics, Receptors, CCR5 metabolism, Transduction, Genetic, Endonucleases metabolism, Genetic Engineering, Genetic Vectors, HIV Reverse Transcriptase genetics, Lentivirus genetics, Mutation genetics, RNA, Messenger metabolism
- Abstract
TAL-effector nucleases (TALENs) are attractive tools for sequence-specific genome modifications, but their delivery still remains problematic. It is well known that the presence of multiple sequence repeats in TALEN genes hampers the use of lentiviral vectors. We report that lentiviral vectors readily package full-length vector mRNAs encoding TALENs, but recombination during reverse transcription prevents successful delivery. We reasoned that preventing reverse transcription of lentiviral-vector RNA would allow transfer of TALENs as mRNA. We demonstrate that lentiviral particles containing genetically inactivated reverse transcriptase (RT) mediated efficient transduction of cultured cells and supported transient transgene expression. For proof-of-principle, we transferred CCR5- and TCR-specific TALEN pairs for efficient targeted genome editing and abrogated expression for each of the receptor proteins in different cell lines. Combining the high specificity of TALENs with efficient lentiviral gene delivery should advance genome editing in vitro and potentially in vivo, and RT-deficient lentiviral vectors may be useful for transient expression of various other genes-of-interest.
- Published
- 2014
- Full Text
- View/download PDF
120. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.
- Author
-
Holkers M, Cathomen T, and Gonçalves MA
- Subjects
- DNA, Viral administration & dosage, Endonucleases genetics, Genetic Vectors administration & dosage, HEK293 Cells, HeLa Cells, Humans, Adenoviridae genetics, DNA, Viral genetics, Gene Transfer Techniques, Genetic Vectors genetics
- Abstract
Transcription activator-like effector nucleases (TALENs) are designed to cut the genomic DNA at specific chromosomal positions. The resulting DNA double strand break activates cellular repair pathways that can be harnessed for targeted genome modifications. TALENs thus constitute a powerful tool to interrogate the function of DNA sequences within complex genomes. Moreover, their high DNA cleavage activity combined with a low cytotoxicity make them excellent candidates for applications in human gene therapy. Full exploitation of these large and repeat-bearing nucleases in human cell types will benefit largely from using the adenoviral vector (AdV) technology. The genetic stability and the episomal nature of AdV genomes in conjunction with the availability of a large number of AdV serotypes able to transduce various human cell types make it possible to achieve high-level and transient expression of TALENs in numerous target cells, regardless of their mitotic state. Here, we describe a set of protocols detailing the rescue, propagation and purification of TALEN-encoding AdVs. Moreover, we describe procedures for the characterization and quantification of recombinant viral DNA present in the resulting AdV preparations. The protocols are preceded by information about their underlying principles and applied in the context of second-generation capsid-modified AdVs expressing TALENs targeted to the AAVS1 "safe harbor" locus on human chromosome 19., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
121. Translating the genomic revolution - targeted genome editing in primates.
- Author
-
Cathomen T and Ehl S
- Subjects
- Animals, Clustered Regularly Interspaced Short Palindromic Repeats genetics, Genomics, Macaca genetics, Models, Animal, RNA, Small Untranslated, Animals, Genetically Modified, Embryo, Mammalian, Endonucleases genetics, Gene Targeting methods, Genome, Primates genetics
- Published
- 2014
- Full Text
- View/download PDF
122. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity.
- Author
-
Mussolino C, Alzubi J, Fine EJ, Morbitzer R, Cradick TJ, Lahaye T, Bao G, and Cathomen T
- Subjects
- Cells, Cultured, DNA Cleavage, Deoxyribonucleases chemistry, Genetic Loci, HEK293 Cells, HeLa Cells, Humans, Interleukin Receptor Common gamma Subunit genetics, Protein Engineering, Receptors, CCR5 genetics, Deoxyribonucleases metabolism, Genome, Human
- Abstract
Designer nucleases have been successfully employed to modify the genomes of various model organisms and human cell types. While the specificity of zinc-finger nucleases (ZFNs) and RNA-guided endonucleases has been assessed to some extent, little data are available for transcription activator-like effector-based nucleases (TALENs). Here, we have engineered TALEN pairs targeting three human loci (CCR5, AAVS1 and IL2RG) and performed a detailed analysis of their activity, toxicity and specificity. The TALENs showed comparable activity to benchmark ZFNs, with allelic gene disruption frequencies of 15-30% in human cells. Notably, TALEN expression was overall marked by a low cytotoxicity and the absence of cell cycle aberrations. Bioinformatics-based analysis of designer nuclease specificity confirmed partly substantial off-target activity of ZFNs targeting CCR5 and AAVS1 at six known and five novel sites, respectively. In contrast, only marginal off-target cleavage activity was detected at four out of 49 predicted off-target sites for CCR5- and AAVS1-specific TALENs. The rational design of a CCR5-specific TALEN pair decreased off-target activity at the closely related CCR2 locus considerably, consistent with fewer genomic rearrangements between the two loci. In conclusion, our results link nuclease-associated toxicity to off-target cleavage activity and corroborate TALENs as a highly specific platform for future clinical translation., (© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2014
- Full Text
- View/download PDF
123. Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.
- Author
-
Bobis-Wozowicz S, Galla M, Alzubi J, Kuehle J, Baum C, Schambach A, and Cathomen T
- Subjects
- Animals, Cell Line, Gene Knockout Techniques, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Humans, K562 Cells, Mice, Retroviridae genetics, Endonucleases genetics, Gene Transfer Techniques, Genetic Vectors metabolism
- Abstract
Designer nucleases, like zinc-finger nucleases (ZFNs), represent valuable tools for targeted genome editing. Here, we took advantage of the gamma-retroviral life cycle and produced vectors to transfer ZFNs in the form of protein, mRNA and episomal DNA. Transfer efficacy and ZFN activity were assessed in quantitative proof-of-concept experiments in a human cell line and in mouse embryonic stem cells. We demonstrate that retrovirus-mediated protein transfer (RPT), retrovirus-mediated mRNA transfer (RMT), and retrovirus-mediated episome transfer (RET) represent powerful methodologies for transient protein delivery or protein expression. Furthermore, we describe complementary strategies to augment ZFN activity after gamma-retroviral transduction, including serial transduction, proteasome inhibition, and hypothermia. Depending on vector dose and target cell type, gene disruption frequencies of up to 15% were achieved with RPT and RMT, and >50% gene knockout after RET. In summary, non-integrating gamma-retroviral vectors represent a versatile tool to transiently deliver ZFNs to human and mouse cells.
- Published
- 2014
- Full Text
- View/download PDF
124. Efficient designer nuclease-based homologous recombination enables direct PCR screening for footprintless targeted human pluripotent stem cells.
- Author
-
Merkert S, Wunderlich S, Bednarski C, Beier J, Haase A, Dreyer AK, Schwanke K, Meyer J, Göhring G, Cathomen T, and Martin U
- Subjects
- Cells, Cultured, DNA End-Joining Repair, Gene Knockout Techniques, Gene Targeting, Genetic Loci, Humans, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells metabolism, Oligodeoxyribonucleotides metabolism, Pluripotent Stem Cells cytology, Polymerase Chain Reaction, Endonucleases metabolism, Homologous Recombination, Pluripotent Stem Cells metabolism
- Abstract
Genetic engineering of human induced pluripotent stem cells (hiPSCs) via customized designer nucleases has been shown to be significantly more efficient than conventional gene targeting, but still typically depends on the introduction of additional genetic selection elements. In our study, we demonstrate the efficient nonviral and selection-independent gene targeting in human pluripotent stem cells (hPSCs). Our high efficiencies of up to 1.6% of gene-targeted hiPSCs, accompanied by a low background of randomly inserted transgenes, eliminated the need for antibiotic or fluorescence-activated cell sorting selection, and allowed the use of short donor oligonucleotides for footprintless gene editing. Gene-targeted hiPSC clones were established simply by direct PCR screening. This optimized approach allows targeted transgene integration into safe harbor sites for more predictable and robust expression and enables the straightforward generation of disease-corrected, patient-derived iPSC lines for research purposes and, ultimately, for future clinical applications.
- Published
- 2014
- Full Text
- View/download PDF
125. TALE-PvuII fusion proteins--novel tools for gene targeting.
- Author
-
Yanik M, Alzubi J, Lahaye T, Cathomen T, Pingoud A, and Wende W
- Subjects
- Binding Sites, Cell Line, DNA Cleavage, DNA-Binding Proteins chemistry, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, DNA-Cytosine Methylases genetics, Gene Targeting methods, Homeodomain Proteins genetics, Humans, Models, Molecular, Protein Conformation, Protein Multimerization, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins toxicity, Substrate Specificity, DNA-Cytosine Methylases metabolism, Homeodomain Proteins metabolism, Recombinant Fusion Proteins metabolism
- Abstract
Zinc finger nucleases (ZFNs) consist of zinc fingers as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. This architecture is also used by TALE nucleases (TALENs), in which the DNA-binding modules of the ZFNs have been replaced by DNA-binding domains based on transcription activator like effector (TALE) proteins. Both TALENs and ZFNs are programmable nucleases which rely on the dimerization of FokI to induce double-strand DNA cleavage at the target site after recognition of the target DNA by the respective DNA-binding module. TALENs seem to have an advantage over ZFNs, as the assembly of TALE proteins is easier than that of ZFNs. Here, we present evidence that variant TALENs can be produced by replacing the catalytic domain of FokI with the restriction endonuclease PvuII. These fusion proteins recognize only the composite recognition site consisting of the target site of the TALE protein and the PvuII recognition sequence (addressed site), but not isolated TALE or PvuII recognition sites (unaddressed sites), even at high excess of protein over DNA and long incubation times. In vitro, their preference for an addressed over an unaddressed site is > 34,000-fold. Moreover, TALE-PvuII fusion proteins are active in cellula with minimal cytotoxicity.
- Published
- 2013
- Full Text
- View/download PDF
126. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.
- Author
-
Pelascini LP, Maggio I, Liu J, Holkers M, Cathomen T, and Gonçalves MA
- Subjects
- DNA Breaks, Double-Stranded, Endodeoxyribonucleases chemistry, Endodeoxyribonucleases metabolism, HEK293 Cells, HeLa Cells, Histone Deacetylase Inhibitors pharmacology, Humans, Hypoxanthine Phosphoribosyltransferase genetics, Mesenchymal Stem Cells metabolism, Myoblasts metabolism, Endodeoxyribonucleases genetics, Gene Knockout Techniques methods, Genetic Vectors genetics, Histone Deacetylases metabolism, Integrases genetics, Lentivirus genetics, Zinc Fingers
- Abstract
Zinc-finger nucleases (ZFNs) work as dimers to induce double-stranded DNA breaks (DSBs) at predefined chromosomal positions. In doing so, they constitute powerful triggers to edit and to interrogate the function of genomic sequences in higher eukaryotes. A preferred route to introduce ZFNs into somatic cells relies on their cotransduction with two integrase-defective lentiviral vectors (IDLVs) each encoding a monomer of a functional heterodimeric pair. The episomal nature of IDLVs diminishes the risk of genotoxicity and ensures the strict transient expression profile necessary to minimize deleterious effects associated with long-term ZFN activity. However, by deploying IDLVs and conventional lentiviral vectors encoding HPRT1- or eGFP-specific ZFNs, we report that DSB formation at target alleles is limited after IDLV-mediated ZFN transfer. This IDLV-specific underperformance stems, to a great extent, from the activity of chromatin-remodeling histone deacetylases (HDACs). Importantly, the prototypic and U.S. Food and Drug Administration-approved inhibitors of metal-dependent HDACs, trichostatin A and vorinostat, respectively, did not hinder illegitimate recombination-mediated repair of targeted chromosomal DSBs. This allowed rescuing IDLV-mediated site-directed mutagenesis to levels approaching those achieved by using their isogenic chromosomally integrating counterparts. Hence, HDAC inhibition constitutes an efficacious expedient to incorporate in genome-editing strategies based on transient IDLV-mediated ZFN expression. Finally, we compared two of the most commonly used readout systems to measure targeted gene knockout activities based on restriction and mismatch-sensitive endonucleases. These experiments indicate that these enzymatic assays display a similar performance.
- Published
- 2013
- Full Text
- View/download PDF
127. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.
- Author
-
Bloom K, Ely A, Mussolino C, Cathomen T, and Arbuthnot P
- Subjects
- Animals, Base Sequence, Cell Line, DNA Replication, Disease Models, Animal, Genetic Therapy, Genetic Vectors, Hep G2 Cells, Hepatitis B pathology, Hepatitis B therapy, Humans, Mice, Molecular Sequence Data, Mutagenesis, Protein Engineering, Transfection, DNA, Circular genetics, DNA, Viral genetics, Deoxyribonucleases genetics, Deoxyribonucleases physiology, Hepatitis B virus genetics, Hepatitis B virus physiology, Virus Replication
- Abstract
Chronic hepatitis B virus (HBV) infection remains an important global health problem. Stability of the episomal covalently closed circular HBV DNA (cccDNA) is largely responsible for the modest curative efficacy of available therapy. Since licensed anti-HBV drugs have a post-transcriptional mechanism of action, disabling cccDNA is potentially of therapeutic benefit. To develop this approach, we engineered mutagenic transcription activator-like effector nucleases (TALENs) that target four HBV-specific sites within the viral genome. TALENs with cognate sequences in the S or C open-reading frames (ORFs) efficiently disrupted sequences at the intended sites and suppressed markers of viral replication. Following triple transfection of cultured HepG2.2.15 cells under mildly hypothermic conditions, the S TALEN caused targeted mutation in ~35% of cccDNA molecules. Markers of viral replication were also inhibited in vivo in a murine hydrodynamic injection model of HBV replication. HBV target sites within S and C ORFs of the injected HBV DNA were mutated without evidence of toxicity. These findings are the first to demonstrate a targeted nuclease-mediated disruption of HBV cccDNA. Efficacy in vivo also indicates that these engineered nucleases have potential for use in treatment of chronic HBV infection.
- Published
- 2013
- Full Text
- View/download PDF
128. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.
- Author
-
Holkers M, Maggio I, Liu J, Janssen JM, Miselli F, Mussolino C, Recchia A, Cathomen T, and Gonçalves MA
- Subjects
- Chromosomes, Human, DNA Breaks, Double-Stranded, Genetic Loci, Genetic Vectors, HEK293 Cells, HeLa Cells, Humans, Transduction, Genetic, Adenoviridae genetics, Bacterial Proteins genetics, Deoxyribonucleases genetics, HIV-1 genetics
- Abstract
The array of genome editing strategies based on targeted double-stranded DNA break formation have recently been enriched through the introduction of transcription activator-like type III effector (TALE) nucleases (TALENs). To advance the testing of TALE-based approaches, it will be crucial to deliver these custom-designed proteins not only into transformed cell types but also into more relevant, chromosomally stable, primary cells. Viral vectors are among the most effective gene transfer vehicles. Here, we investigated the capacity of human immunodeficiency virus type 1- and adenovirus-based vectors to package and deliver functional TALEN genes into various human cell types. To this end, we attempted to assemble particles of these two vector classes, each encoding a monomer of a TALEN pair targeted to a bipartite sequence within the AAVS1 'safe harbor' locus. Vector DNA analyses revealed that adenoviral vectors transferred intact TALEN genes, whereas lentiviral vectors failed to do so, as shown by their heterogeneously sized proviruses in target cells. Importantly, adenoviral vector-mediated TALEN gene delivery resulted in site-specific double-stranded DNA break formation at the intended AAVS1 target site at similarly high levels in both transformed and non-transformed cells. In conclusion, we demonstrate that adenoviral, but not lentiviral, vectors constitute a valuable TALEN gene delivery platform.
- Published
- 2013
- Full Text
- View/download PDF
129. RNA guides genome engineering.
- Author
-
Mussolino C and Cathomen T
- Subjects
- Animals, Endonucleases metabolism, Genome, Humans, Mice, RNA chemistry, RNA metabolism, Biotechnology methods, Genetic Engineering methods, RNA genetics
- Published
- 2013
- Full Text
- View/download PDF
130. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.
- Author
-
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, Chuah M, Cornetta K, Davies KE, Dickson JG, Duchateau P, Flotte TR, Gaudet D, Gersbach CA, Gilbert R, Glorioso J, Herzog RW, High KA, Huang W, Huard J, Joung JK, Liu D, Liu D, Lochmüller H, Lustig L, Martens J, Massie B, Mavilio F, Mendell JR, Nathwani A, Ponder K, Porteus M, Puymirat J, Samulski J, Takeda S, Thrasher A, VandenDriessche T, Wei Y, Wilson JM, Wilton SD, Wolfe JH, and Gao G
- Subjects
- Biomedical Research organization & administration, Biomedical Research trends, Humans, International Cooperation, Genetic Therapy methods, Genomics methods
- Published
- 2013
- Full Text
- View/download PDF
131. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration.
- Author
-
Yuan Q, Loya K, Rani B, Möbus S, Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, Cantz T, and Sharma AD
- Subjects
- Animals, Aryl Hydrocarbon Receptor Nuclear Translocator metabolism, Cell Proliferation, Hepatectomy, Mice, Hepatocytes physiology, Liver Regeneration, MicroRNAs metabolism
- Abstract
Unlabelled: The tightly controlled replication of hepatocytes in liver regeneration and uncontrolled proliferation of tumor cells in hepatocellular carcinoma (HCC) are often modulated by common regulatory pathways. Several microRNAs (miRNAs) are involved in HCC progression by modulating posttranscriptional expression of multiple target genes. miR-221, which is frequently up-regulated in HCCs, delays fulminant liver failure in mice by inhibiting apoptosis, indicating a pleiotropic role of miR-221 in hepatocytes. Here, we hypothesize that modulation of miR-221 targets in primary hepatocytes enhances proliferation, providing novel clues for enhanced liver regeneration. We demonstrate that miR-221 enhances proliferation of in vitro cultivated primary hepatocytes. Furthermore, applying two-thirds partial hepatectomy as a surgically induced liver regeneration model we show that adeno-associated virus-mediated overexpression of miR-221 in the mouse liver also accelerates hepatocyte proliferation in vivo. miR-221 overexpression leads to rapid S-phase entry of hepatocytes during liver regeneration. In addition to the known targets p27 and p57, we identify Aryl hydrocarbon nuclear translocator (Arnt) messenger RNA (mRNA) as a novel target of miR-221, which contributes to the pro-proliferative activity of miR-221., Conclusion: miR-221 overexpression accelerates hepatocyte proliferation. Pharmacological intervention targeting miR-221 may thus be therapeutically beneficial in liver failure by preventing apoptosis and by inducing liver regeneration., (Copyright © 2012 American Association for the Study of Liver Diseases.)
- Published
- 2013
- Full Text
- View/download PDF
132. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting.
- Author
-
Rahman SH, Bobis-Wozowicz S, Chatterjee D, Gellhaus K, Pars K, Heilbronn R, Jacobs R, and Cathomen T
- Subjects
- Blotting, Western, Cell Cycle Checkpoints physiology, Cell Line, DNA Primers genetics, DNA Repair physiology, Deoxyribonucleases metabolism, Genotype, Green Fluorescent Proteins metabolism, Humans, Mesenchymal Stem Cells, Real-Time Polymerase Chain Reaction, Dependovirus genetics, Gene Targeting methods, Genetic Engineering methods, Genetic Vectors genetics, Indoles therapeutic use, Oximes therapeutic use, Transduction, Genetic methods
- Abstract
Parameters that regulate or affect the cell cycle or the DNA repair choice between non-homologous end-joining and homology-directed repair (HDR) are excellent targets to enhance therapeutic gene targeting. Here, we have evaluated the impact of five cell-cycle modulating drugs on targeted genome engineering mediated by DNA double-strand break (DSB)-inducing nucleases, such as zinc-finger nucleases (ZFNs). For a side-by-side comparison, we have established four reporter cell lines by integrating a mutated EGFP gene into either three transformed human cell lines or primary umbilical cord-derived mesenchymal stromal cells (UC-MSCs). After treatment with different cytostatic drugs, cells were transduced with adeno-associated virus (AAV) vectors that encode a nuclease or a repair donor to rescue EGFP expression through DSB-induced HDR. We show that transient cell-cycle arrest increased AAV transduction and AAV-mediated HDR up to six-fold in human cell lines and ten-fold in UC-MSCs, respectively. Targeted gene correction was observed in up to 34% of transduced cells. Both the absolute and the relative gene-targeting frequencies were dependent on the cell type, the cytostatic drug, the vector dose, and the nuclease. Treatment of cells with the cyclin-dependent kinase inhibitor indirubin-3'-monoxime was especially promising as this compound combined high stimulatory effects with minimal cytotoxicity. In conclusion, indirubin-3'-monoxime significantly improved AAV transduction and the efficiency of AAV/ZFN-mediated gene targeting and may thus represent a promising compound to enhance DSB-mediated genome engineering in human stem cells, such as UC-MSCs, which hold great promise for future clinical applications.
- Published
- 2013
- Full Text
- View/download PDF
133. TALE nucleases: tailored genome engineering made easy.
- Author
-
Mussolino C and Cathomen T
- Subjects
- Animals, DNA-Binding Proteins chemistry, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Endonucleases chemistry, Humans, Protein Structure, Tertiary, Stem Cells metabolism, Transcriptional Activation, Zinc Fingers, Endonucleases genetics, Endonucleases metabolism, Genetic Engineering methods, Genome genetics
- Abstract
Custom-made designer nucleases have evolved into an indispensable platform to precisely alter complex genomes for basic research, biotechnology, synthetic biology, or human gene therapy. In this review we describe how transcription activator-like effector nucleases (TALENs) have rapidly developed into a chief technology for targeted genome editing in different model organisms as well as human stem cells. We summarize the technological background and provide an overview of the current state-of-the-art of TALENs with regard to activity and specificity of these nucleases for targeted genome engineering., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
134. Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.
- Author
-
Voigt K, Gogol-Döring A, Miskey C, Chen W, Cathomen T, Izsvák Z, and Ivics Z
- Subjects
- Binding Sites, Computational Biology methods, DNA-Binding Proteins metabolism, Female, Gene Transfer Techniques, Genome, Human, HeLa Cells, Humans, Plasmids, Transfection, Transposases metabolism, DNA Transposable Elements genetics, DNA-Binding Proteins genetics, Genetic Engineering methods, Mutagenesis, Insertional, Transposases genetics, Zinc Fingers genetics
- Abstract
The Sleeping Beauty (SB) transposon is a nonviral, integrating vector system with proven efficacy in preclinical animal models, and thus holds promise for future clinical applications. However, SB has a close-to-random insertion profile that could lead to genotoxic effects, thereby presenting a potential safety issue. We evaluated zinc finger (ZF) DNA-binding domains (DBDs) for their abilities to introduce a bias into SB's insertion profile. E2C, that binds a unique site in the erbB-2 gene, mediated locus-specific transposon insertions at low frequencies. A novel ZF targeting LINE1 repeats, ZF-B, showed specific binding to an 18-bp site represented by ~12,000 copies in the human genome. We mapped SB insertions using linear-amplification (LAM)-PCR and Illumina sequencing. Targeted insertions with ZF-B peaked at approximately fourfold enrichment of transposition around ZF-B binding sites yielding ~45% overall frequency of insertion into LINE1. A decrease in the ZF-B dataset with respect to transposon insertions in genes was found, suggesting that LINE1 repeats act as a sponge that "soak up" a fraction of SB insertions and thereby redirect them away from genes. Improvements in ZF technology and a careful choice of targeted genomic regions may improve the safety profile of SB for future clinical applications.
- Published
- 2012
- Full Text
- View/download PDF
135. Retargeting transposon insertions by the adeno-associated virus Rep protein.
- Author
-
Ammar I, Gogol-Döring A, Miskey C, Chen W, Cathomen T, Izsvák Z, and Ivics Z
- Subjects
- Binding Sites, DNA metabolism, DNA-Binding Proteins genetics, HeLa Cells, Humans, Plasmids genetics, Protein Interaction Domains and Motifs, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins metabolism, Transposases chemistry, Transposases genetics, Viral Proteins genetics, Virus Integration, DNA Transposable Elements, DNA-Binding Proteins metabolism, Dependovirus genetics, Viral Proteins metabolism
- Abstract
The Sleeping Beauty (SB), piggyBac (PB) and Tol2 transposons are promising instruments for genome engineering. Integration site profiling of SB, PB and Tol2 in human cells showed that PB and Tol2 insertions were enriched in genes, whereas SB insertions were randomly distributed. We aimed to introduce a bias into the target site selection properties of the transposon systems by taking advantage of the locus-specific integration system of adeno-associated virus (AAV). The AAV Rep protein binds to Rep recognition sequences (RRSs) in the human genome, and mediates viral integration into nearby sites. A series of fusion constructs consisting of the N-terminal DNA-binding domain of Rep and the transposases or the N57 domain of SB were generated. A plasmid-based transposition assay showed that Rep/SB yielded a 15-fold enrichment of transposition at a particular site near a targeted RRS. Genome-wide insertion site analysis indicated that an approach based on interactions between the SB transposase and Rep/N57 enriched transgene insertions at RRSs. We also provide evidence of biased insertion of the PB and Tol2 transposons. This study provides a comparative insight into target site selection properties of transposons, as well as proof-of-principle for targeted chromosomal transposition by composite protein-protein and protein-DNA interactions.
- Published
- 2012
- Full Text
- View/download PDF
136. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects.
- Author
-
Ramirez CL, Certo MT, Mussolino C, Goodwin MJ, Cradick TJ, McCaffrey AP, Cathomen T, Scharenberg AM, and Joung JK
- Subjects
- Cell Line, DNA Cleavage, DNA End-Joining Repair, Deoxyribonucleases, Type II Site-Specific genetics, Genes, Reporter, Green Fluorescent Proteins genetics, HEK293 Cells, Humans, Mutagenesis, Protein Engineering methods, Zinc Fingers, Deoxyribonucleases, Type II Site-Specific metabolism, Recombinational DNA Repair
- Abstract
Engineered zinc finger nucleases (ZFNs) induce DNA double-strand breaks at specific recognition sequences and can promote efficient introduction of desired insertions, deletions or substitutions at or near the cut site via homology-directed repair (HDR) with a double- and/or single-stranded donor DNA template. However, mutagenic events caused by error-prone non-homologous end-joining (NHEJ)-mediated repair are introduced with equal or higher frequency at the nuclease cleavage site. Furthermore, unintended mutations can also result from NHEJ-mediated repair of off-target nuclease cleavage sites. Here, we describe a simple and general method for converting engineered ZFNs into zinc finger nickases (ZFNickases) by inactivating the catalytic activity of one monomer in a ZFN dimer. ZFNickases show robust strand-specific nicking activity in vitro. In addition, we demonstrate that ZFNickases can stimulate HDR at their nicking site in human cells, albeit at a lower frequency than by the ZFNs from which they were derived. Finally, we find that ZFNickases appear to induce greatly reduced levels of mutagenic NHEJ at their target nicking site. ZFNickases thus provide a promising means for inducing HDR-mediated gene modifications while reducing unwanted mutagenesis caused by error-prone NHEJ.
- Published
- 2012
- Full Text
- View/download PDF
137. Highly efficient zinc-finger nuclease-mediated disruption of an eGFP transgene in keratinocyte stem cells without impairment of stem cell properties.
- Author
-
Höher T, Wallace L, Khan K, Cathomen T, and Reichelt J
- Subjects
- Animals, Base Sequence, Biological Assay, Cell Aggregation, Cell Count, Cell Death, Cell Differentiation, Epidermal Cells, Flow Cytometry, Fluorescent Antibody Technique, Genotype, Mice, Molecular Sequence Data, Endonucleases metabolism, Green Fluorescent Proteins genetics, Keratinocytes metabolism, Stem Cells metabolism, Transgenes genetics, Zinc Fingers
- Abstract
Zinc-finger nucleases (ZFNs) are sequence-specific genome engineering tools with great potential for the development of gene therapies. The achievement of permanent cures through gene therapy requires targeting of stem cells but the effects and/or side effects of ZFN treatment on adult stem cell potency are largely unknown. Keratinocyte stem cells (KSCs) are attractive candidates for the development of gene therapies as their isolation, culture and grafting are well established. We derived KSCs from eGFP-transgenic mice and knocked out eGFP expression by disrupting the open reading frame with specific ZFNs in cell culture. EGFP-negative KSCs were then used as a model system to study the impact of ZFN treatment on stem cell potential. We achieved high gene disruption efficiencies with up to 18% eGFP-negative KSCs. As expected, ZFN cytotoxicity increased with rising ZFN concentrations. However, the ratio of correctly targeted KSCs among total treated cells was similar at different ZFN doses. Most importantly, our in vitro assays showed that ZFN-treated KSCs maintained their stem cell potential. They retained the capacity to both self-renew and form fully differentiated epidermal equivalents in culture. Moreover, they were able to form spherical aggregates in suspension culture, a characteristic hallmark shared with other stem cell types, and they expressed the in vivo KSC markers K15, NFATc1 and Sox9. Our data suggest that the stem cell potential of KSCs is not impaired by highly efficient ZFN treatment.
- Published
- 2012
- Full Text
- View/download PDF
138. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.
- Author
-
Händel EM, Gellhaus K, Khan K, Bednarski C, Cornu TI, Müller-Lerch F, Kotin RM, Heilbronn R, and Cathomen T
- Subjects
- Endonucleases metabolism, Genetic Vectors, Genotype, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Humans, Mutation, Zinc Fingers, Dependovirus genetics, Endonucleases genetics, Genome, Human
- Abstract
Zinc-finger nucleases (ZFNs) have become a valuable tool for targeted genome engineering. Based on the enzyme's ability to create a site-specific DNA double-strand break, ZFNs promote genome editing by activating the cellular DNA damage response, including homology-directed repair (HDR) and nonhomologous end-joining. The goal of this study was (i) to demonstrate the versatility of combining the ZFN technology with a vector platform based on adeno-associated virus (AAV), and (ii) to assess the toxicity evoked by this platform. To this end, human cell lines that harbor enhanced green fluorescence protein (EGFP) reporters were generated to easily quantify the frequencies of gene deletion, gene disruption, and gene correction. We demonstrated that ZFN-encoding AAV expression vectors can be employed to induce large chromosomal deletions or to disrupt genes in up to 32% of transduced cells. In combination with AAV vectors that served as HDR donors, the AAV-ZFN platform was utilized to correct a mutation in EGFP in up to 6% of cells. Genome editing on the DNA level was confirmed by genotyping. Although cell cycle profiling revealed a modest G2/M arrest at high AAV-ZFN vector doses, platform-induced apoptosis could not be detected. In conclusion, the combined AAV-ZFN vector technology is a useful tool to edit the human genome with high efficiency. Because AAV vectors can transduce many cell types relevant for gene therapy, the ex vivo and in vivo delivery of ZFNs via AAV vectors will be of great interest for the treatment of inherited disorders.
- Published
- 2012
- Full Text
- View/download PDF
139. A novel zinc-finger nuclease platform with a sequence-specific cleavage module.
- Author
-
Schierling B, Dannemann N, Gabsalilow L, Wende W, Cathomen T, and Pingoud A
- Subjects
- Base Sequence, DNA chemistry, DNA metabolism, DNA-Binding Proteins chemistry, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Deoxyribonucleases, Type II Site-Specific chemistry, Deoxyribonucleases, Type II Site-Specific genetics, HEK293 Cells, Humans, Osmolar Concentration, Protein Structure, Tertiary, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins metabolism, Substrate Specificity, DNA Cleavage, Deoxyribonucleases, Type II Site-Specific metabolism, Zinc Fingers
- Abstract
Zinc-finger nucleases (ZFNs) typically consist of three to four zinc fingers (ZFs) and the non-specific DNA-cleavage domain of the restriction endonuclease FokI. In this configuration, the ZFs constitute the binding module and the FokI domain the cleavage module. Whereas new binding modules, e.g. TALE sequences, have been considered as alternatives to ZFs, no efforts have been undertaken so far to replace the catalytic domain of FokI as the cleavage module in ZFNs. Here, we have fused a three ZF array to the restriction endonuclease PvuII to generate an alternative ZFN. While PvuII adds an extra element of specificity when combined with ZFs, ZF-PvuII constructs must be designed such that only PvuII sites with adjacent ZF-binding sites are cleaved. To achieve this, we introduced amino acid substitutions into PvuII that alter K(m) and k(cat) and increase fidelity. The optimized ZF-PvuII fusion constructs cleave DNA at addressed sites with a >1000-fold preference over unaddressed PvuII sites in vitro as well as in cellula. In contrast to the 'analogous' ZF-FokI nucleases, neither excess of enzyme over substrate nor prolonged incubation times induced unaddressed cleavage in vitro. These results present the ZF-PvuII platform as a valid alternative to conventional ZFNs.
- Published
- 2012
- Full Text
- View/download PDF
140. DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8.
- Author
-
Alex M, Weger S, Mietzsch M, Slanina H, Cathomen T, and Heilbronn R
- Subjects
- Binding Sites, DNA Helicases chemistry, DNA Helicases genetics, DNA Replication, DNA-Binding Proteins genetics, Dependovirus chemistry, Dependovirus genetics, Dependovirus physiology, HeLa Cells, Helper Viruses genetics, Helper Viruses metabolism, Humans, Parvoviridae Infections virology, Protein Structure, Tertiary, Protein Transport, Simplexvirus genetics, Viral Proteins chemistry, Viral Proteins genetics, Virus Replication, DNA Helicases metabolism, DNA-Binding Proteins metabolism, Dependovirus enzymology, Simplexvirus metabolism, Terminal Repeat Sequences, Viral Proteins metabolism
- Abstract
Herpes simplex virus (HSV) helper functions for (AAV) replication comprise HSV ICP8 and helicase-primase UL5/UL52/UL8. Here we show that N-terminal amino acids of AAV Rep78 that contact the Rep-binding site within the AAV inverted terminal repeat (ITR) are required for ternary-complex formation with infected-cell protein 8 (ICP8) on AAV single-strand DNA (ssDNA) in vitro and for colocalization in nuclear replication domains in vivo. Our data suggest that HSV-dependent AAV replication is initiated by Rep contacting the AAV ITR and by cooperative binding of ICP8 on AAV ssDNA.
- Published
- 2012
- Full Text
- View/download PDF
141. Zinc-finger nucleases-based genome engineering to generate isogenic human cell lines.
- Author
-
Dreyer AK and Cathomen T
- Subjects
- Amino Acid Sequence, Base Sequence, Genetic Loci genetics, Genotyping Techniques, Green Fluorescent Proteins genetics, Humans, K562 Cells, Molecular Sequence Data, Plasmids genetics, Transfection, Deoxyribonucleases chemistry, Deoxyribonucleases metabolism, Genetic Engineering methods, Genome genetics, Zinc Fingers
- Abstract
Customized zinc-finger nucleases (ZFNs) have developed into a promising technology to precisely alter mammalian genomes for biomedical research, biotechnology, or human gene therapy. In the context of synthetic biology, the targeted integration of a transgene or reporter cassette into a "neutral site" of the human genome, such as the AAVS1 locus, permits the generation of isogenic human cell lines with two major advantages over standard genetic manipulation techniques: minimal integration site-dependent effects on the transgene and, vice versa, no functional perturbation of the host-cell transcriptome. Here we describe in detail how ZFNs can be employed to target integration of a transgene cassette into the AAVS1 locus and how to characterize the targeted cells by PCR-based genotyping.
- Published
- 2012
- Full Text
- View/download PDF
142. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
- Author
-
Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, and Cathomen T
- Subjects
- Bacterial Proteins chemistry, DNA Cleavage, Deoxyribonucleases genetics, Gene Targeting, Genome, Human, HEK293 Cells, Humans, Protein Engineering, Protein Structure, Tertiary, Trans-Activators chemistry, Transcription Activator-Like Effectors, DNA-Binding Proteins chemistry, Deoxyribonucleases chemistry, Deoxyribonucleases metabolism, Genetic Engineering
- Abstract
Sequence-specific nucleases represent valuable tools for precision genome engineering. Traditionally, zinc-finger nucleases (ZFNs) and meganucleases have been used to specifically edit complex genomes. Recently, the DNA binding domains of transcription activator-like effectors (TALEs) from the bacterial pathogen Xanthomonas have been harnessed to direct nuclease domains to desired genomic loci. In this study, we tested a panel of truncation variants based on the TALE protein AvrBs4 to identify TALE nucleases (TALENs) with high DNA cleavage activity. The most favorable parameters for efficient DNA cleavage were determined in vitro and in cellular reporter assays. TALENs were designed to disrupt an EGFP marker gene and the human loci CCR5 and IL2RG. Gene editing was achieved in up to 45% of transfected cells. A side-by-side comparison with ZFNs showed similar gene disruption activities by TALENs but significantly reduced nuclease-associated cytotoxicities. Moreover, the CCR5-specific TALEN revealed only minimal off-target activity at the CCR2 locus as compared to the corresponding ZFN, suggesting that the TALEN platform enables the design of nucleases with single-nucleotide specificity. The combination of high nuclease activity with reduced cytotoxicity and the simple design process marks TALENs as a key technology platform for targeted modifications of complex genomes.
- Published
- 2011
- Full Text
- View/download PDF
143. On target? Tracing zinc-finger-nuclease specificity.
- Author
-
Mussolino C and Cathomen T
- Subjects
- Humans, DNA metabolism, Endodeoxyribonucleases metabolism, Substrate Specificity, Zinc Fingers
- Abstract
In two independent studies, researchers experimentally test the cleavage specificity of zinc-finger nucleases across the genome.
- Published
- 2011
- Full Text
- View/download PDF
144. Zinc-finger nucleases for somatic gene therapy: the next frontier.
- Author
-
Rahman SH, Maeder ML, Joung JK, and Cathomen T
- Subjects
- Genetic Engineering methods, Genetic Therapy methods, Genome, Human, HIV Infections therapy, Humans, Receptors, CCR5 genetics, Endonucleases genetics, Genetic Therapy trends, Zinc Fingers
- Abstract
Zinc-finger nucleases (ZFNs) are a powerful tool that can be used to edit the human genome ad libitum. The technology has experienced remarkable development in the last few years with regard to both the target site specificity and the engineering platforms used to generate zinc-finger proteins. As a result, two phase I clinical trials aimed at knocking out the CCR5 receptor in T cells isolated from HIV patients to protect these lymphocytes from infection with the virus have been initiated. Moreover, ZFNs have been successfully employed to knockout or correct disease-related genes in human stem cells, including hematopoietic precursor cells and induced pluripotent stem cells. Targeted genome engineering approaches in multipotent and pluripotent stem cells hold great promise for future strategies geared toward correcting inborn mutations for personalized cell replacement therapies. This review describes how ZFNs have been applied to models of gene therapy, discusses the opportunities and the risks associated with this novel technology, and suggests future directions for their safe application in therapeutic genome engineering.
- Published
- 2011
- Full Text
- View/download PDF
145. Adding fingers to an engineered zinc finger nuclease can reduce activity.
- Author
-
Shimizu Y, Şöllü C, Meckler JF, Adriaenssens A, Zykovich A, Cathomen T, and Segal DJ
- Subjects
- Base Sequence, Binding Sites, Cells, Cultured, Endonucleases genetics, Humans, Kinetics, Models, Biological, Molecular Sequence Data, Protein Engineering, Endonucleases chemistry, Endonucleases metabolism, Zinc Fingers genetics
- Abstract
Zinc finger nucleases (ZFNs) have been used to direct precise modifications of the genetic information in living cells at high efficiency. An important consideration in the design of ZFNs is the number of zinc fingers that are required for efficient and specific cleavage. We examined dimeric ZFNs composed of [1]+[1], [2]+[2], [3]+[3], [4]+[4], [5]+[5], and [6]+[6] zinc fingers, targeting 6, 12, 18, 24, 30, and 36 bp, respectively. We found that [1]+[1] and [2]+[2] fingers supported neither in vitro cleavage nor single-strand annealing in a cell-based recombination assay. An optimal ZFN activity was observed for [3]+[3] and [4]+[4] fingers. Surprisingly, [5]+[5] and [6]+[6] fingers exhibited significantly reduced activity. While the extra fingers were not found to dramatically increase toxicity, directly inhibit recombination, or perturb the ZFN target site, we demonstrate the ability of subsets of three fingers in six-finger arrays to bind independently to regions of the target site, possibly explaining the decrease in activity. These results have important implications for the design of new ZFNs, as they show that in some cases an excess of fingers may actually negatively affect the performance of engineered multifinger proteins. Maximal ZFN activity will require an optimization of both DNA binding affinity and specificity.
- Published
- 2011
- Full Text
- View/download PDF
146. MicroRNA-221 regulates FAS-induced fulminant liver failure.
- Author
-
Sharma AD, Narain N, Händel EM, Iken M, Singhal N, Cathomen T, Manns MP, Schöler HR, Ott M, and Cantz T
- Subjects
- Animals, Apoptosis, Hepatocytes, Mice, Mice, Inbred BALB C, Liver Failure, Acute etiology, MicroRNAs physiology, fas Receptor physiology
- Abstract
Unlabelled: Death receptor-mediated apoptosis of hepatocytes contributes to hepatitis and fulminant liver failure. MicroRNAs (miRNAs), 19-25 nucleotide-long noncoding RNAs, have been implicated in the posttranscriptional regulation of the various apoptotic pathways. Here we report that global loss of miRNAs in hepatic cells leads to increased cell death in a model of FAS/CD95 receptor-induced apoptosis. miRNA profiling of murine liver identified 11 conserved miRNAs, which were up-regulated in response to FAS-induced fulminant liver failure. We show that ectopic expression of miR-221, one of the highly up-regulated miRNAs in response to apoptosis, protects primary hepatocytes and hepatoma cells from apoptosis. Importantly, in vivo overexpression of miR-221 by adeno-associated virus serotype 8 (AAV8) delays FAS-induced fulminant liver failure in mice. We additionally demonstrate that miR-221 regulates hepatic expression of p53 up-regulated modulator of apoptosis (Puma), a well-known proapoptotic member of the Bcl2 protein family., Conclusion: We identified miR-221 as a potent posttranscriptional regulator of FAS-induced apoptosis. miR-221 may serve as a potential therapeutic target for the treatment of hepatitis and liver failure., (Copyright © 2011 American Association for the Study of Liver Diseases.)
- Published
- 2011
- Full Text
- View/download PDF
147. Targeted genome editing in pluripotent stem cells using zinc-finger nucleases.
- Author
-
Bobis-Wozowicz S, Osiak A, Rahman SH, and Cathomen T
- Subjects
- Animals, Cell Culture Techniques, Cells, Cultured, Culture Media, DNA Repair, Deoxyribonucleases metabolism, Embryonic Stem Cells cytology, Enzyme Assays, Gene Deletion, Genetic Engineering methods, Genotype, Mice, Transfection methods, Deoxyribonucleases genetics, Embryonic Stem Cells physiology, Gene Knock-In Techniques, Gene Knockdown Techniques, Genome, Zinc Fingers genetics
- Abstract
Zinc-finger nucleases (ZFNs) are designer nucleases capable of cleaving a prespecified target DNA within complex genomes. ZFNs consist of a non-specific endonuclease domain fused to an engineered DNA-binding domain that tethers the nuclease activity to the chosen chromosomal site. The endonuclease-induced DNA double strand break triggers a cellular DNA damage response, resulting in double strand break repair by either accurate homologous recombination (HR) or error-prone non-homologous end-joining (NHEJ). Thus, ZFNs are powerful tools for targeted genome engineering in a variety of mammalian cell types, including embryonic (ESCs) and induced pluripotent stem cells (iPSCs). As a paradigm for genome editing in pluripotent stem cells, we describe the use of ZFNs in murine ESCs for generating knockout alleles by NHEJ without selection or by HR employing different selection schemes., (Copyright © 2011. Published by Elsevier Inc.)
- Published
- 2011
- Full Text
- View/download PDF
148. Zinc-finger nuclease based genome surgery: it's all about specificity.
- Author
-
Händel EM and Cathomen T
- Subjects
- Animals, DNA Damage, Endonucleases metabolism, Humans, Sensitivity and Specificity, Endonucleases genetics, Genetic Engineering methods, Genetic Therapy methods, Zinc Fingers genetics
- Abstract
Therapeutic genome engineering is a hallmark of gene therapy but only recent technological advances have permitted the modification of complex genomes in a targeted fashion. Zinc-finger nucleases (ZFNs) have developed into a major playmaker in the genome engineering field and have been employed to trigger the targeted editing of genomes at over 50 gene loci in 11 model organisms, including fruitfly, zebrafish and rat, with allelic frequencies reaching the double digit percentage range. Moreover, ZFN-mediated genome surgery in primary human cells has become a reality and two phase I clinical trials aiming at knocking out the CCR5 receptor in T cells isolated from HIV patients to protect these cells from infection with the virus have been initiated. Considering that specificity is closely linked to ZFN activity and ZFN-associated toxicity, this parameter has been and will be a key quality in any therapeutic application of the designer nucleases. This review summarizes the technological innovations that have successfully catapulted ZFNs into the genome engineering arena and provides an overview of the current state of the art of these nucleases with reference to human gene therapy.
- Published
- 2011
- Full Text
- View/download PDF
149. Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases.
- Author
-
Osiak A, Radecke F, Guhl E, Radecke S, Dannemann N, Lütge F, Glage S, Rudolph C, Cantz T, Schwarz K, Heilbronn R, and Cathomen T
- Subjects
- Animals, Base Sequence, Cell Line, Tumor, Chromosomes, Mammalian metabolism, Embryonic Stem Cells cytology, Humans, Metaphase, Mice, Mice, Knockout, Molecular Sequence Data, Pluripotent Stem Cells cytology, Pluripotent Stem Cells metabolism, Embryonic Stem Cells metabolism, Endonucleases metabolism, Gene Knockout Techniques, Zinc Fingers genetics
- Abstract
Gene knockout in murine embryonic stem cells (ESCs) has been an invaluable tool to study gene function in vitro or to generate animal models with altered phenotypes. Gene targeting using standard techniques, however, is rather inefficient and typically does not exceed frequencies of 10(-6). In consequence, the usage of complex positive/negative selection strategies to isolate targeted clones has been necessary. Here, we present a rapid single-step approach to generate a gene knockout in mouse ESCs using engineered zinc-finger nucleases (ZFNs). Upon transient expression of ZFNs, the target gene is cleaved by the designer nucleases and then repaired by non-homologous end-joining, an error-prone DNA repair process that introduces insertions/deletions at the break site and therefore leads to functional null mutations. To explore and quantify the potential of ZFNs to generate a gene knockout in pluripotent stem cells, we generated a mouse ESC line containing an X-chromosomally integrated EGFP marker gene. Applying optimized conditions, the EGFP locus was disrupted in up to 8% of ESCs after transfection of the ZFN expression vectors, thus obviating the need of selection markers to identify targeted cells, which may impede or complicate downstream applications. Both activity and ZFN-associated cytotoxicity was dependent on vector dose and the architecture of the nuclease domain. Importantly, teratoma formation assays of selected ESC clones confirmed that ZFN-treated ESCs maintained pluripotency. In conclusion, the described ZFN-based approach represents a fast strategy for generating gene knockouts in ESCs in a selection-independent fashion that should be easily transferrable to other pluripotent stem cells.
- Published
- 2011
- Full Text
- View/download PDF
150. Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator.
- Author
-
Rother M, Krohn S, Kania G, Vanhoutte D, Eisenreich A, Wang X, Westermann D, Savvatis K, Dannemann N, Skurk C, Hilfiker-Kleiner D, Cathomen T, Fechner H, Rauch U, Schultheiss HP, Heymans S, Eriksson U, Scheibenbogen C, and Poller W
- Subjects
- Adult, Animals, Autoimmune Diseases pathology, Biomimetics, Cell Movement drug effects, Cells, Cultured, Cysteine-Rich Protein 61 genetics, Cysteine-Rich Protein 61 pharmacology, Disease Models, Animal, Female, Gene Transfer Techniques, Humans, Leukocytes, Mononuclear cytology, Leukocytes, Mononuclear drug effects, Liver cytology, Liver drug effects, Male, Mice, Mice, Inbred BALB C, Middle Aged, Monocytes cytology, Monocytes drug effects, Myocarditis pathology, Peptides, Cyclic pharmacology, Recombinant Proteins pharmacology, Spleen cytology, Spleen drug effects, Autoimmune Diseases metabolism, Autoimmune Diseases prevention & control, Cell Movement physiology, Cysteine-Rich Protein 61 metabolism, Myocarditis metabolism, Myocarditis prevention & control
- Abstract
Background: CCN1 is an evolutionary ancient matricellular protein that modulates biological processes associated with tissue repair. Induction at sites of injury was observed in conditions ranging from skin wounds to cardiac diseases, including ischemic and inflammatory cardiomyopathy. Here, we provide evidence of a novel function of CCN1 as a modulator of immune cell migration., Methods and Results: to understand the role of CCN1 in cardiomyopathies and to evaluate its therapeutic potential, we overexpressed CCN1 using an adenoviral hepatotropic vector in murine experimental autoimmune myocarditis, a model of human inflammatory cardiomyopathy. CCN1 gene transfer significantly reduced cardiac disease score and immune cell infiltration. In vivo tracking of hemagglutinin epitope-tagged CCN1 revealed binding to spleen macrophages but not to cardiomyocytes. Unexpectedly, CCN1 therapy left cardiac chemokine and cytokine expression unchanged but instead strongly inhibited the migration of spleen macrophages and lymphocytes, as evidenced by ex vivo transwell assays. In accordance with the ex vivo data, in vitro preincubation with CCN1 diminished transwell migration of human monocytes and abrogated their chemotactic response to monocyte chemoattractant protein-1, macrophage inflammatory protein-1α, and stromal cell-derived factor-1α. Further mechanistic studies showed that CCN1-driven modulation of immune cell migration is mimicked in part by cyclic RGD peptides currently in clinical evaluation for cancer therapy., Conclusions: our proof-of-concept study suggests investigation of CCN1 as a novel, endogenous "parent compound" for chemotaxis modulation and of cyclic RGD peptides as a class of partially CCN1-mimetic drugs with immediate potential for clinical evaluation in cardiac diseases associated with chronic pathogenic inflammation.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.